Klaus Moosmayer, Ph.D., Chief Ethics, Risk & Compliance Officer of Novartis

- What should RegTechs learn or consider working better with established companies, or even to win them as customers?
- Any recommendations to how established companies and RegTechs can be actively engaged in fighting for example against corruption?
- What do you think established companies do better in compliance tasks than 5 years ago?
- What do you think are the three major upcoming trends in Technology in context of Risk Ethics Compliance tasks?

Episode 1

Klaus Moosmayer, Ph.D.
Chief Ethics, Risk & Compliance
Officer of Novartis
[linkedin]
Nationality: German
Year of Birth: 1968
Klaus Moosmayer, Ph.D., has been Chief Ethics, Risk &
Compliance Officer of Novartis since 2018. He is a member
of the Executive Committee of Novartis.
Mr. Moosmayer previously was chief compliance officer of
Siemens AG, a position he held since 2014. During his 18-
year career at Siemens, Mr. Moosmayer also served as
chief counsel compliance from 2009 to 2013, and as
compliance operating officer from 2007 to 2009.
Mr. Moosmayer received his doctor of jurisprudence from
the University of Freiburg in Germany, and passed his first
and second state examination in law in Germany. He is
internationally recognized in the field of compliance. He
serves as vice chair of the Business at OECD (BIAC)
executive board and served as chair of its Anti-Corruption
Committee from 2013 to 2020. He is co-founder and chair
of the European Chief Compliance and Integrity Officers’
Forum; and co-chair of the B20 Integrity & Compliance Task
Force under the G20 presidency of Saudi Arabia. He served
as co-chair of the B20 Integrity & Compliance Task Force
under the G20 presidency of Argentina in 2018, and as
chair of the B20 Integrity & Compliance Task Force under
the G20 presidency of Germany in 2017.